Lead toxicosis remains the primary cause of death in wild populations of California condors ( Gymnogyps californianus). Many condors require medical intervention with lead chelation therapy, among other conservation measures, to survive in the wild. An analysis of historical medical records of California condors admitted for lead exposure to the Los Angeles Zoo and Botanical Gardens (LA Zoo) between 1997 and 2012 was performed to investigate clinical presentation, radiographic findings, and treatment along with the potential impact of these factors on recovery and successful release back into the wild. Of 100 individual condors presented to the LA Zoo for suspected lead toxicosis during this period, 84 condors had records for initial laboratory blood lead levels. For these 84 condors (40 [47.6%] females and 44 [52.4%] males), 277 initial laboratory blood lead levels in total were recorded because of repeated admissions. Thirty-two (38%) condors were admitted once to the zoo and 62% were admitted two or more times. Clinical signs were not observed in 87.5% of the condors admitted with median blood lead concentrations of 26 μg/dl. Of the radiographs taken on initial presentation, 65% did not show evidence of gastrointestinal metallic foreign bodies. Various treatments protocols with edetatum calcium disodium, dimercaptosuccinic acid, and lactated Ringer's solution were documented in the medical records. Of the 277 admissions, 154 admissions had a recorded outcome posttreatment of which 140 (91%) admissions were released back to the wild. This study contributes to a better understanding of how intervention and therapeutic approaches have been essential for the recovery, release, and sustainability of these birds as a wild population. Consistency in data collection of California condors admitted for diagnosis and treatment of lead toxicosis is needed to better assess the impacts of medical interventions.

Download full-text PDF

Source
http://dx.doi.org/10.1638/2018-0022.1DOI Listing

Publication Analysis

Top Keywords

california condors
16
condors admitted
16
medical records
12
lead toxicosis
12
blood lead
12
condors
10
lead
9
analysis historical
8
historical medical
8
records california
8

Similar Publications

In last 100 years or so, much information has been accumulated on avian karyology, genetics, physiology, biochemistry and evolution. The chicken genome project generated genomic resources used in comparative studies, elucidating fundamental evolutionary processes, much of it funded by the economic importance of domestic fowl (which are also excellent model species in many areas). Studying karyotypes and whole genome sequences revealed population processes, evolutionary biology, and genome function, uncovering the role of repetitive sequences, transposable elements and gene family expansion.

View Article and Find Full Text PDF

Lead poisoning remains the leading cause of diagnosed death for critically endangered California condors, which are annually monitored for lead exposure via blood tests. Blood tests are generally reflective of acute lead exposure. Since condors are victims to both chronic and acute lead exposure, measuring bone, which in humans is reflective of years to decades worth of exposure, is a valuable biomarker.

View Article and Find Full Text PDF
Article Synopsis
  • A study analyzed a large cohort of patients with dural arteriovenous fistulas (dAVFs) presenting cognitive impairment, called dAVFs-CI, to understand their characteristics compared to those without cognitive issues.
  • Findings showed that venous hypertension and sinus stenosis were common in dAVFs-CI, with these patients having more arterial feeders and draining veins, making their condition more severe.
  • Closing the dAVF may help improve symptoms in some cases, highlighting the importance of timely diagnosis and treatment.*
View Article and Find Full Text PDF
Article Synopsis
  • [F]DCFPyL is used for imaging prostate cancer patients with biochemically recurrent prostate cancer (BRPCa), and this meta-analysis assesses its detection efficiency across various studies, including the key CONDOR trial.
  • The study analyzed data from 17 articles involving 2,252 patients, finding that the overall detection rate of [F]DCFPyL is 0.73, which is lower than previous estimates, especially in relation to serum PSA levels.
  • The results indicate that detection efficiency is better in patients with higher PSA levels but remains unaffected by the rate of PSA doubling time; these findings suggest that stricter study criteria may have influenced the lowered detection rates over time.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!